Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Ganglion Cell Function After Repeated Intravitreous Ranibizumab in Diabetic Macular Edema

NCT02055911 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT02055911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02055911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Ganglion Cell Function After Repeated Intravitreous Ranibizumab in Diabetic Macular Edema
Lead sponsor
Federal University of São Paulo
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2014
Completion date
July 31, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema